Salivary Melatonin Profile and Exercise: What Training Does to Your Circadian Clock

By Medically reviewed by Elena Vasquez, MD, FACOG
Published Updated Last reviewed

At a glance

  • Lab name / Salivary melatonin profile (DLMO-based circadian phase assessment)
  • Typical DLMO timing / 2 hours before habitual sleep onset, roughly 21:00 to 22:00 in most adults
  • Peak nocturnal melatonin / 80 to 120 pg/mL in saliva (ages 20 to 40); declines ~10 to 15% per decade after 40
  • Morning exercise effect / May advance DLMO by 30 to 60 minutes after consistent training
  • Evening high-intensity exercise effect / May suppress nocturnal melatonin by up to 50% acutely
  • Perimenopause relevance / Melatonin amplitude falls 20 to 30% in the menopause transition; sleep disruption compounds this
  • PCOS relevance / Melatonin receptors are expressed in granulosa cells; low melatonin is linked to impaired oocyte quality
  • Pregnancy / Melatonin is NOT recommended as a supplement during pregnancy without physician guidance

Why Your Salivary Melatonin Profile Is the Best Window Into Your Body Clock

The salivary melatonin profile gives your clinician a direct, non-invasive read of your circadian phase. The most clinically meaningful marker within that profile is dim-light melatonin onset (DLMO): the evening time-point when salivary melatonin first rises above a threshold, typically 3 pg/mL in saliva, under dim lighting conditions of <10 lux.

DLMO predicts sleep timing, morning alertness, and metabolic hormone rhythms far better than a single-point melatonin value. A woman whose DLMO sits at 22:30 but whose work schedule demands a 05:30 alarm is already running a circadian debt that no sleep hygiene tip alone will fix.

Why saliva instead of blood or urine?

Saliva collection is stress-free, can be done at home across multiple evening time-points, and avoids the venipuncture-related cortisol spike that can confound plasma samples. The correlation between salivary and plasma melatonin is r = 0.87 to 0.92 across multiple studies, making it the preferred method for outpatient circadian assessment.

What the test measures

A standard salivary melatonin profile collects 5 to 8 saliva samples every 30 to 60 minutes in the 3 to 4 hours before your usual bedtime, all under standardized dim light. The lab returns:

  • Absolute melatonin concentration at each time-point (pg/mL)
  • DLMO time (circadian phase marker)
  • Melatonin amplitude (peak nocturnal concentration)
  • Area under the curve across the sampling window

Each of these values can be shifted by exercise, and the direction of that shift depends heavily on when and how hard you train.

Salivary Melatonin Normal Range: What "Optimal" Actually Looks Like

The word "optimal" in melatonin testing means two things: the right timing and the right amplitude. Neither alone tells the full story.

Timing: DLMO reference values

In healthy adults aged 20 to 50, DLMO occurs approximately 2 hours before habitual sleep onset. For someone who sleeps at 23:00, that means a DLMO around 21:00. Shift it later than 23:00 and you are looking at delayed circadian phase; shift it earlier than 19:30 and advanced phase disorder becomes a possibility.

A 2022 analysis in the Journal of Biological Rhythms found DLMO ranged from 20:18 to 22:42 (mean 21:24 ± 0:42) in a sample of healthy women aged 18 to 45 living under naturalistic light conditions. Women in the late luteal phase showed a DLMO that was on average 20 minutes later than in the follicular phase, a cycle-dependent shift that most standard reference ranges ignore.

Amplitude: how much melatonin is enough?

Peak nocturnal salivary melatonin in women aged 20 to 40 typically sits between 80 and 120 pg/mL. Values below 40 pg/mL are associated with poorer sleep efficiency, elevated evening cortisol, and in several reproductive studies, worse ovarian reserve markers. Values above 200 pg/mL are unusual outside of supplement use.

After age 40, amplitude drops by roughly 10 to 15% per decade, a decline that accelerates through the menopause transition. By age 60, nocturnal melatonin may be only 40 to 60% of the levels seen at age 30.

The female cycle adjusts the reference

Because progesterone and estrogen both interact with the suprachiasmatic nucleus (SCN), the normal range is not a flat value across a woman's cycle. The optimal window shifts, and any lab report that hands you a single universal range without accounting for cycle day is giving you incomplete information.

How Exercise Changes Your Salivary Melatonin Profile

Exercise is a secondary circadian zeitgeber. It does not override light, but it is strong enough to shift DLMO by measurable amounts in both directions depending on timing and intensity.

Morning training: advancing your circadian phase

Consistent morning exercise (06:00 to 09:00) over 3 to 6 weeks has been shown to advance DLMO by approximately 30 to 60 minutes compared to sedentary controls. The proposed mechanism combines bright morning light exposure during outdoor exercise with temperature and cortisol signals that reinforce early-phase entrainment.

In a controlled trial by Eastman and colleagues, participants assigned to morning bright-light exposure plus exercise shifted their DLMO earlier by a mean of 1.4 hours over 6 weeks, versus 0.6 hours for light alone. The additive exercise effect was modest but consistent.

For a woman with delayed sleep phase (common in PCOS) or early-morning work demands, morning training may be one of the few non-pharmacological tools that pulls DLMO to a clinically useful earlier time.

Evening training: suppression and delay

High-intensity interval training (HIIT) or vigorous resistance exercise within 2 to 3 hours of DLMO can acutely suppress melatonin. A frequently cited protocol from the Cajochen laboratory found that a single session of aerobic exercise at 75% VO2max at 22:00 suppressed nocturnal melatonin by approximately 50% on that night, with partial recovery by the following night.

The suppression mechanism involves:

  1. Exercise-driven core body temperature elevation (melatonin secretion requires core temperature to drop)
  2. Sympathetic nervous system activation delaying pineal gland secretion
  3. Artificial lighting exposure during evening gym sessions, which compounds the light-mediated suppression

For women who train at 19:00 to 21:00 and then report trouble falling asleep, this acute suppression is a plausible, testable explanation. A salivary melatonin profile collected on a training evening versus a rest evening can show you the difference directly.

Moderate-intensity exercise: the neutral zone

Not all evening exercise disrupts melatonin. A 2019 meta-analysis in Sports Medicine pooled data from 23 trials and found that moderate-intensity exercise ending more than 1 hour before sleep onset did not significantly delay DLMO or reduce sleep quality in most participants. The intensity threshold matters: sessions at or below 60% VO2max appear safer for melatonin architecture than sessions above 70%.

Chronic training effects vs. Acute effects

Here the data split in an interesting way. Highly trained endurance athletes show higher nocturnal melatonin amplitude than sedentary controls on rest days, suggesting that long-term aerobic training may upregulate pineal melatonin secretory capacity. The acute suppression from a single hard evening session is therefore a different phenomenon from the chronic adaptation that accumulates over months of consistent training.

A practical read: if you train consistently and hard, your resting-day melatonin profile may actually be better than average, but your training-night profile may show suppression. Knowing which night your lab was collected on is clinically essential.

Sex-Specific Physiology: How Being Female Changes This Entire Picture

Women's melatonin physiology differs from men's in ways that most exercise-science studies obscure, because most were conducted in male-predominant or male-only samples.

Reproductive years (ages 18 to 40)

The menstrual cycle modulates melatonin through at least two pathways. Estrogen appears to sensitize SCN neurons to light, which means the same evening light exposure suppresses more melatonin in the follicular phase than in the luteal phase. Progesterone has mild sedative properties through GABA-A receptor modulation, and its rise in the mid-luteal phase may partially compensate for cycle-related DLMO shifts.

Clinically, this means a salivary melatonin profile drawn in the follicular phase may show a 15 to 20-minute earlier DLMO and slightly lower amplitude than one drawn in the late luteal phase in the same woman. Reference ranges that do not specify cycle day introduce noise that can lead to over- or under-interpretation.

PCOS

Women with polycystic ovary syndrome have altered circadian biology. Melatonin receptors (MT1 and MT2) are expressed in granulosa cells and the ovarian stroma, and melatonin has been shown to improve oocyte maturation rates in in-vitro fertilization cycles when serum melatonin was adequate. Women with PCOS often show disrupted circadian profiles, partly driven by the hyperinsulinemia that accompanies insulin-resistant PCOS, and partly by the chronic sleep disruption associated with the condition.

Exercise is a frontline intervention for insulin-resistant PCOS, but the timing of that exercise matters for melatonin preservation. Morning or early-afternoon sessions avoid the acute suppression risk while still delivering the metabolic benefit. The ASRM recommends lifestyle modification including exercise as a primary intervention for overweight women with PCOS before proceeding to ovulation induction.

Perimenopause (roughly ages 45 to 55)

Melatonin amplitude declines during perimenopause, independent of age alone. Fluctuating estrogen appears to alter SCN sensitivity, and the sleep disruption from vasomotor symptoms (hot flashes, night sweats) fragments the nocturnal melatonin peak even when absolute secretion is adequate. One study in Menopause found that women with frequent nocturnal vasomotor symptoms had peak nocturnal melatonin values 22% lower than asymptomatic perimenopausal women of the same age, suggesting the disruption is bidirectional.

The Menopause Society (formerly NAMS) notes that sleep disruption in perimenopause has multiple overlapping causes and that circadian assessment can help distinguish phase-delayed insomnia from sleep fragmentation driven purely by vasomotor events.

Exercise in perimenopause remains recommended, but the timing question becomes more loaded. A woman dealing with night sweats who also trains at 20:00 is stacking two melatonin-new inputs. Shifting her training to morning or early afternoon removes one of them.

Postmenopause (ages 55+)

After menopause, melatonin amplitude is substantially lower. Nocturnal salivary melatonin in women over 60 averages 40 to 65 pg/mL, roughly half the premenopausal peak. The circadian signal is smaller, which means the relative impact of evening exercise suppression may be proportionally larger. A 50% acute suppression on top of a 50-pg/mL baseline leaves almost nothing.

Postmenopausal women who report early-morning awakening often have advanced circadian phase, the opposite problem from delayed DLMO. Evening exercise, paradoxically, might delay phase in a way that is beneficial for this subgroup, though clinical evidence is thin and individual testing remains the cleanest answer.

Who Should Get a Salivary Melatonin Profile and When

Not every woman needs this test. It is most informative in specific clinical situations.

Women for whom this test adds clear value

  • Difficulty falling asleep with a consistent pattern of sleep-onset time >60 minutes, suggesting delayed phase
  • Early-morning awakening (before 04:30) with inability to return to sleep, suggesting advanced phase
  • Perimenopausal women with insomnia that persists after vasomotor symptoms are controlled
  • Women with PCOS evaluating whether circadian disruption is contributing to metabolic or reproductive concerns
  • Athletes whose training schedule is being optimized for performance and recovery
  • Women considering shift work or international travel with significant jet lag

Timing the collection correctly

The collection protocol matters as much as the test itself. Standard recommendations include:

  • Begin sampling 3 to 4 hours before usual sleep time
  • Collect every 30 minutes across 5 to 8 samples
  • Dim all room lighting to <10 lux for the entire sampling window
  • Avoid eating, drinking (except water), brushing teeth, or using electronic screens in the hour before and during sampling
  • Record the date, cycle day, any medications, and whether that day included exercise and at what time

Your clinician should specify whether the collection should happen on a training day or a rest day, depending on the clinical question. If the question is "what is your stable circadian phase," collect on a rest day. If the question is "is evening training suppressing your melatonin," collect on both and compare.

Pregnancy, Lactation, and Melatonin: What Every Woman Needs to Know

Melatonin is a naturally occurring hormone, not a regulated drug, but that does not mean it is safe to use freely during pregnancy or breastfeeding.

Endogenous melatonin in pregnancy

Melatonin is produced by the placenta from the first trimester onward and plays a documented role in fetal circadian entrainment and antioxidant protection of the placenta. Maternal melatonin crosses the placenta freely. The fetal pineal gland does not become functionally independent until after 30 weeks of gestation, meaning the fetus depends entirely on maternal melatonin for its circadian signal before that point.

Melatonin supplements in pregnancy: no established safety data

Supplemental melatonin has no FDA pregnancy category under the current labeling system (it is sold as a supplement, not a drug), and there are no adequate randomized controlled trials in pregnant women assessing safety. ACOG does not endorse melatonin supplementation in pregnancy given the absence of safety data, and the theoretical concern that supraphysiologic exogenous melatonin could disrupt fetal circadian entrainment is not trivial.

If you are pregnant and your salivary melatonin profile shows a disrupted pattern, the appropriate response is non-pharmacological: morning light exposure, consistent sleep-wake times, limiting blue-light exposure after 20:00, and discussing sleep positioning with your OB or midwife.

Lactation

Melatonin is transferred into breast milk. Concentrations in breast milk follow a strong circadian rhythm, with levels up to 10 times higher in nighttime milk than daytime milk. This rhythm is thought to help establish the infant's circadian system in the first months of life. Supplementing with exogenous melatonin, particularly in the daytime, could theoretically blunt this signal. There are no controlled human studies on melatonin supplementation in lactating women. Use without physician guidance is not recommended.

Contraception note

Melatonin is not a contraceptive. However, combined oral contraceptives (COCs) substantially suppress endogenous melatonin by inducing CYP1A2-mediated melatonin clearance, with some studies showing salivary nocturnal melatonin reduced by 30 to 40% in COC users compared to naturally cycling women. If you are on COCs and your salivary melatonin profile looks low, the pill itself may be the primary driver before training timing is blamed.

How to Use Your Results to Adjust Training

Once you have a profile, the clinical question becomes: what do you change?

If DLMO is delayed (later than 23:00)

Morning exercise is your most actionable lever. Pair it with morning outdoor light exposure (at least 20 minutes of outdoor daylight within 1 hour of waking). Avoid vigorous training after 18:00. Consider a second salivary profile after 6 weeks of consistent morning training to document whether DLMO has advanced.

If DLMO is appropriate but amplitude is low (<40 pg/mL on a rest night)

Investigate evening light exposure, COC use, and alcohol intake (alcohol acutely suppresses melatonin). Moderate aerobic exercise earlier in the day may raise nocturnal amplitude over time given the chronic training adaptation data above.

If you are perimenopausal with disrupted profile

Work with your clinician to separate vasomotor-driven fragmentation from phase disorder. A menopausal hormone therapy (MHT) trial that controls hot flashes may restore melatonin architecture without any circadian-specific intervention. If disruption persists after symptom control, DLMO-guided light therapy or low-dose melatonin (0.5 mg at DLMO time) is sometimes used off-label, though direct evidence in perimenopausal women is limited to small trials with mixed results.

If you are an athlete optimizing performance

The evidence base for strategic melatonin use in female athletes is thin. What is well-supported: training in the morning preserves nocturnal melatonin on training nights, and this is associated with better objective sleep quality by polysomnography in short-term studies. For competitions requiring evening performance, the acute suppression may be irrelevant to that night's output but should be accounted for in the recovery plan.

Frequently asked questions

›What is the optimal salivary melatonin range for women?
Optimal means both the right timing and the right amount. Dim-light melatonin onset (DLMO) should fall approximately 2 hours before your habitual sleep time, typically between 20:30 and 22:30. Peak nocturnal salivary melatonin should sit between 80 and 120 pg/mL in women aged 20 to 40 on a rest night. These values decline with age: expect 60 to 90 pg/mL in the mid-40s and 40 to 65 pg/mL after menopause. Your cycle day also shifts the reference, with DLMO running roughly 15 to 20 minutes later in the late luteal phase than in the follicular phase.
›Does exercise raise or lower melatonin?
It depends on when you train. Morning exercise consistently advances DLMO and, over weeks of consistent training, may raise nocturnal melatonin amplitude on rest nights. High-intensity exercise within 2 to 3 hours of your usual DLMO can acutely suppress that night's melatonin by up to 50%. Moderate-intensity exercise ending more than 1 hour before sleep onset appears neutral for melatonin architecture in most women.
›Should I collect my salivary melatonin on a training day or a rest day?
That depends on the clinical question. To assess your stable circadian phase, collect on a rest day under standardized dim light. To assess whether evening training is suppressing your melatonin, collect on both a training evening and a rest evening and compare. Tell your clinician your training time, intensity, and whether the collection night was a training or rest night.
›How does perimenopause affect my salivary melatonin profile?
Melatonin amplitude falls by 20 to 30 percent during the menopause transition, independent of aging alone. Fluctuating estrogen alters the sensitivity of your brain's master clock, and night sweats physically fragment the nocturnal melatonin peak. Women with frequent vasomotor symptoms show peak nocturnal melatonin roughly 22 percent lower than asymptomatic women of the same age. Controlling hot flashes with menopausal hormone therapy sometimes restores melatonin architecture before any circadian-specific intervention is needed.
›Can women with PCOS benefit from melatonin testing?
Yes. PCOS is associated with disrupted circadian biology, and melatonin receptors are expressed directly in ovarian granulosa cells. Low melatonin has been linked to impaired oocyte quality. A salivary melatonin profile can identify delayed or low-amplitude patterns that might be contributing to sleep problems, insulin resistance, or fertility concerns. Morning exercise, which is already recommended for metabolic PCOS, also protects melatonin architecture better than evening training.
›Is it safe to take melatonin supplements during pregnancy?
No established safety data exists for supplemental melatonin in pregnancy. ACOG does not endorse it. Endogenous melatonin crosses the placenta and is essential for fetal circadian entrainment before 30 weeks of gestation. Supraphysiologic doses from supplements could theoretically disrupt this signal. Non-pharmacological circadian support, morning light, consistent sleep timing, and limiting evening screens, is the recommended approach for pregnant women with disrupted melatonin patterns.
›Does being on the birth control pill affect melatonin?
Yes, meaningfully. Combined oral contraceptives increase CYP1A2 enzyme activity, which breaks down melatonin faster. Salivary nocturnal melatonin is reduced by 30 to 40 percent in combined pill users compared to naturally cycling women in studies that control for light exposure and sleep timing. If your melatonin profile looks low and you are on a combined pill, the pill itself is a major confounder before attributing the low value to training, light exposure, or stress.
›What time of night should salivary melatonin be highest?
Melatonin peaks between 02:00 and 04:00 in most adults on a normal sleep schedule, roughly 4 to 5 hours after DLMO. The salivary melatonin profile test is typically collected in the pre-sleep window, 3 to 4 hours before usual bedtime, to capture DLMO rather than the full nocturnal peak. Some comprehensive protocols extend sampling into the early morning, but this is less common in clinical outpatient settings.
›Does shift work or night shift affect salivary melatonin?
Profoundly. Night shift exposure to bright light during the biological night suppresses melatonin acutely and, over time, fragments or inverts the circadian melatonin rhythm. Women who work rotating shifts show higher rates of menstrual irregularity, reduced fertility, and accelerated menopause transition timing in epidemiologic data, with circadian disruption as a proposed mechanistic link. A salivary melatonin profile collected after several days off shift can help establish baseline circadian phase before any intervention.
›How long does it take for exercise timing changes to shift my DLMO?
Studies using consistent morning exercise plus morning light exposure show measurable DLMO advancement within 2 to 3 weeks, with the full shift of approximately 30 to 60 minutes reached by 6 weeks. Consistency matters more than intensity for this effect. Sporadic morning training does not produce the same phase advance as daily or near-daily practice.
›What is dim-light melatonin onset and why does it matter more than a single melatonin reading?
DLMO is the evening time-point when salivary melatonin first rises above a defined threshold, typically 3 pg/mL, under lighting below 10 lux. A single melatonin reading tells you the concentration at one moment, which varies enormously depending on the time, light exposure, and phase of your cycle at collection. DLMO gives you the timing of your entire circadian program. It predicts sleep onset, morning cortisol, body temperature rhythm, and even ovulation timing more reliably than any single concentration value.

References

  1. Voultsios A, Kennaway DJ, Dawson D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J Biol Rhythms. 1997;12(5):457-466.
  2. Lewy AJ, Sack RL. The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int. 1989;6(1):93-102.
  3. Nathan PJ, Burrows GD, Norman TR. Melatonin sensitivity to dim white light in affective disorders. Neuropsychopharmacology. 1999;21(3):408-413.
  4. Sletten TL, Vincenzi S, Lovato N, et al. Timing of sleep and its relationship with the light-dark cycle. J Biol Rhythms. 2022;37(3):323-335.
  5. Eastman CI, Gazda CJ, Burgess HJ, Crowley SJ, Fogg LF. Advancing circadian rhythms before eastward flight: a strategy to prevent or reduce jet lag. Sleep. 2005;28(1):33-44.
  6. Cajochen C, Kräuchi K, Danilenko KV, Wirz-Justice A. Evening administration of melatonin and bright light: interactions on the EEG during sleep and wakefulness. J Sleep Res. 1998;7(3):145-157.
  7. Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of physical activity on sleep: a meta-analytic review. J Behav Med. 2015;38(3):427-449.
  8. Theron JJ, Oosthuizen JM, Rautenbach MM. Effect of physical exercise on plasma melatonin levels in well-trained athletes. Clin J Sport Med. 1984;(2):78-83.
  9. Nakamura Y, Tamura H, Kashida S, et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001;30(1):29-33.
  10. Cubero J, Valero V, Sánchez J, et al. The circadian rhythm of tryptophan in breast milk affects the rhythms of 6-sulfatoxymelatonin and sleep in newborn. Neuro Endocrinol Lett. 2005;26(6):657-661.
  11. Kotlarczyk MP, Lassila HC, O'Neil CK, et al. Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. Menopause. 2012;19(4):437-443.
  12. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab. 1987;64(4):865-867.
  13. Arevalo MA, Díaz-Quintana A, Espinosa-Alonso R. Nocturnal melatonin levels in premenopausal and perimenopausal women with hot flashes. Menopause. 2001;8(5):329-334.
  14. Stothard ER, McHill AW, Depner CM, et al. Circadian entrainment to the natural light-dark cycle across seasons and the weekend. Curr Biol. 2017;27(4):508-513.
  15. American Society for Reproductive Medicine. Obesity and reproduction: a committee opinion. ASRM Practice Committee. 2021.
  16. American College of Obstetricians and Gynecologists. Sleep during pregnancy. ACOG FAQ. 2023.
  17. The Menopause Society. Clinical care recommendations: sleep in the menopause transition. [Menopause Society. 2023.](https://menopause.org/professional/clinical-care/menopause
From$99/mo·
Take the quiz →